Cellectar Biosciences, Inc.CLRBNASDAQ
Loading
Free Cash Flow Growth AcceleratingAccelerating
Percentile Rank100
Studio
Year-over-Year Change

Year-over-year free cash flow growth rate

Latest
51.51%
↑ 429% vs avg
Percentile
P100
Near historical high
Streak
1 yr
Consecutive growthAccelerating
Average
-15.65%
Historical baseline
PeriodValue
202551.51%
2024-43.46%
2023-30.62%
2022-12.06%
2021-62.27%
2020-19.43%
20190.92%
2018-4.05%
2017-36.06%
2016-1.00%